The Severity of Bleeding and Mortality in Trauma Patients Taking Dabigatran.

about

Prevalence of Intracranial Hemorrhage after Blunt Head Trauma in Patients on Pre-injury Dabigatran.Effects of Natural Hirudin and Low Molecular Weight Heparin in Preventing Deep Venous Thrombosis in Aged Patients with Intertrochanteric Fracture.

P2860

Q40065521-BB1F6D83-25C9-4BBB-A55D-1982749CE8BF Q55379899-F0BA615C-240E-43B3-ACD6-C432C8C03DE2

P2860

The Severity of Bleeding and Mortality in Trauma Patients Taking Dabigatran.

Item

http://www.wikidata.org/entity/Q39641019

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

The Severity of Bleeding and Mortality in Trauma Patients Taking Dabigatran.

@en

The Severity of Bleeding and Mortality in Trauma Patients Taking Dabigatran.

@nl

type

Item

label

The Severity of Bleeding and Mortality in Trauma Patients Taking Dabigatran.

@en

The Severity of Bleeding and Mortality in Trauma Patients Taking Dabigatran.

@nl

prefLabel

The Severity of Bleeding and Mortality in Trauma Patients Taking Dabigatran.

@en

The Severity of Bleeding and Mortality in Trauma Patients Taking Dabigatran.

@nl

P1476

The Severity of Bleeding and Mortality in Trauma Patients Taking Dabigatran.

@en

P2093

Angela C Comer

http://www.w3.org/2001/XMLSchema#string

John R Hess

http://www.w3.org/2001/XMLSchema#string

Jon Mark Hirshon

http://www.w3.org/2001/XMLSchema#string

Mayur Narayan

http://www.w3.org/2001/XMLSchema#string

P2860

Dabigatran versus warfarin in patients with atrial fibrillation

Idarucizumab for Dabigatran Reversal

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

Managing bleeding in anticoagulated patients with a focus on novel therapeutic agents.

Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial.

National surveillance of emergency department visits for outpatient adverse drug events.

Dabigatran versus warfarin in the treatment of acute venous thromboembolism.

A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial.

Cardiology patient pages. Prevention of deep vein thrombosis and pulmonary embolism.

P304

238-245

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JEMERMED.2016.05.005

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gordon S. Smith

Zachary D W Dezman

P577

2016-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27364823

http://www.w3.org/2001/XMLSchema#string

P932

5482216

http://www.w3.org/2001/XMLSchema#string

The Severity of Bleeding and Mortality in Trauma Patients Taking Dabigatran.

about

P2860

P2860

The Severity of Bleeding and Mortality in Trauma Patients Taking Dabigatran.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932